Renato Cutrera, Andrea Wolfler, Simonetta Picone, Giovanni A. Rossi, Giuliana Gualberti, Rocco Merolla, . . . Andrea Dotta. (2019). Impact of the 2014 American Academy of Pediatrics recommendation and of the resulting limited financial coverage by the Italian Medicines Agency for palivizumab prophylaxis on the RSV-associated hospitalizations in preterm infants during the 2016-2017 epidemic season: A systematic review of seven Italian reports. BMC.
Chicago Style (17th ed.) CitationRenato Cutrera, et al. Impact of the 2014 American Academy of Pediatrics Recommendation and of the Resulting Limited Financial Coverage by the Italian Medicines Agency for Palivizumab Prophylaxis on the RSV-associated Hospitalizations in Preterm Infants During the 2016-2017 Epidemic Season: A Systematic Review of Seven Italian Reports. BMC, 2019.
MLA (9th ed.) CitationRenato Cutrera, et al. Impact of the 2014 American Academy of Pediatrics Recommendation and of the Resulting Limited Financial Coverage by the Italian Medicines Agency for Palivizumab Prophylaxis on the RSV-associated Hospitalizations in Preterm Infants During the 2016-2017 Epidemic Season: A Systematic Review of Seven Italian Reports. BMC, 2019.